Synthetic Biologics, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Synthetic Biologics, Inc.
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
The Bayh-Dole act of 1980 facilitated deal-making between private-sector firms and research institutions, largely seeding the US biotech industry. Plus, an overview of the latest tech transfer deals.
Experts describe the agile, localized supply chains that will emerge, only perhaps to be forgotten just-in-time for the next crisis.
Gilead, Vetter, Lonza and academic experts share what they’re focusing on to keep producing drugs during the pandemic.
- Gene Therapy, Cell Therapy
- Large Molecule
- Other Names / Subsidiaries
- Adeona Pharmaceuticals, Inc.
- Pipex Pharmaceuticals, Inc.
- Sheffield Pharmaceuticals, Inc.